InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: None

Thursday, 06/02/2016 8:05:22 PM

Thursday, June 02, 2016 8:05:22 PM

Post# of 16911
An article in Psychology Today is one thing, but now national news...the fact that one single "addiction expert" has doubts...my gut tells me larger forces are at play. At least they had the courtesy to interview Braeburn as well...

Patients may also forget the drug is helping them achieve their sobriety, leaving them under the false impression that they don’t need to attend therapy or adjust their lifestyle changes. In turn, rather than addressing the problem, the device could lead to co-abuse and eventually relapse after the six-month period of Probuphine ends, Cidambi said.

However, Sheldon told FoxNews.com that the medication's labeling does idicate that behavior therapy is recommended, and that there is a policy in place regarding coverage for a patient that requires a physician to indicate that the patient has complied with recommendations for additional care.




http://www.foxnews.com/health/2016/06/02/addiction-expert-questions-recently-approved-anti-opioid-implant.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News